In The News

Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids

In Conversation With: Dr Lynn Kirkpatrick, Ensysce Biosciences

Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach

Revolutionizing Pain Relief: The Next Generation of Opioids | Interview with Ensysce Biosciences CEO

As the White House attempts to expand overdose treatment, Ensysce is planning to provide pain relief with overdose protection.

Ensysce Biosciences: A Solution to the Opioid Crisis?

As We Enter “the Most Dangerous Time of the Year”, a Solution to Prescription Opioid Overdose may be in Sight

Dr. Vince Clinical Research Announces Dosing of Ensysce's PF614 Compound in Human Abuse Potential Trial

Women in Pharma: Ensysce Biosciences’ CEO aims to combat prescription drug abuse

Ensysce Featured on Benzinga All Access